B Cell receptor directs the activation of NFAT and NF-κB via distinct molecular mechanisms

Experimental Cell Research

Volumn 291, Issue 1, 2003, Pages 11-24

  Antony, Pierre ^a   Petro, James B ^a   Carlesso, Gianluca ^a   Shinners, Nicholas P ^a   Lowe, John ^a   Khan, Wasif N ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B lymphocytes; Bruton's tyrosine kinase; Calcium; Diacylglycerol; NF B; NFAT; Phospholipase C 2; Signal transduction; Transcription factors; Transgenic knockout; X linked immunodeficiency

Indexed keywords

2 [[2 [[2 [(2 AMINO 3 MERCAPTOPROPYL)AMINO] 3 METHYLPENTYL]OXY] 1 OXO 3 PHENYLPROPYL]AMINO] 4 (METHYLSULFONYL)BUTANOIC ACID ISOPROPYL ESTER; B LYMPHOCYTE RECEPTOR; BISINDOLYLMALEIMIDE; CALCIUM ION; CD5 ANTIGEN; DIACYLGLYCEROL; EGTAZIC ACID; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL)ETHER N,N,N',N' TETRAACETIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOENZYME; PROTEIN KINASE C; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE; RAS PROTEIN; ROTTLERIN; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; GENE CONTROL; MOLECULAR MECHANICS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0242270624     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00338-0     Document Type: Article

References (73)

1. Hsueh R.C., Scheuermann R.H. Tyrosine kinase activation in the decision between growth, differentiation, and death responses initiated from the B cell antigen receptor. Adv. Immunol. 75:2000;283-316.
2. Kurosaki T. Functional dissection of BCR signaling pathways. Curr. Opin. Immunol. 12:2000;276-281.
3. Meffre E., Casellas R., Nussenzweig M.C. Antibody regulation of B cell development. Nat. Immunol. 1:2000;379-385.
4. Rajewsky K. Clonal selection and learning in the antibody system. Nature. 381:1996;751-758.
5. Healy J.I., Dolmetsch R.E., Timmerman L.A., Cyster J.G., Thomas M.L., Crabtree G.R., Lewis R.S., Goodnow C.C. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity. 6:1997;419-428.
6. Dolmetsch R.E., Xu K., Lewis R.S. Calcium oscillations increase the efficiency and specificity of gene expression. Nature. 392:1998;933-936.
7. 2+ response amplitude and duration. Nature. 386:1997;855-858.
8. Kurosaki T., Tsukada S. BLNK connecting Syk and Btk to calcium signals . Immunity. 12:2000;1-5.
9. Rawlings D.J., Saffran D.C., Tsukada S., Largaespada D.A., Grimaldi J.C., Cohen L., Mohr R.N., Bazan J.F., Howard M., Copeland N.G., et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science. 261:1993;358-361.
10. Thomas J.D., Sideras P., Smith C.I., Vorechovsky I., Chapman V., Paul W.E. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science. 261:1993;355-358.
11. Anderson J.S., Teutsch M., Dong Z., Wortis H.H. An essential role for Bruton's tyrosine kinase in the regulation of B-cell apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;10966-10971.
12. Khan W.N., Alt F.W., Gerstein R.M., Malynn B.A., Larsson I., Rathbun G., Davidson L., Muller S., Kantor A.B., Herzenberg L.A., et al. Defective B cell development and function in Btk-deficient mice. Immunity. 3:1995;283-299.
13. Solvason N., Wu W.W., Kabra N., Lund-Johansen F., Roncarolo M.G., Behrens T.W., Grillot D.A., Nunez G., Lees E., Howard M. Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells. J. Exp. Med. 187:1998;1081-1091.
14. 2+ following B-cell receptor activation. Embo. J. 17:1998;1973-1985.
15. 2+ mobilization by X-linked agammaglobulinaemia (XLA) B cells in response to ligation of the B cell receptor (BCR). Clin. Exp. Immunol. 110:1997;386-391.
16. Fruman D.A., Satterthwaite A.B., Witte O.N. Xid-like phenotypes a B cell signalosome takes shape . Immunity. 13:2000;1-3.
17. Scharenberg A.M., Kinet J.P. PtdIns-3,4,5-P3 a regulatory nexus between tyrosine kinases and sustained calcium signals . Cell. 94:1998;5-8.
18. Rodriguez R., Matsuda M., Perisic O., Bravo J., Paul A., Jones N.P., Light Y., Swann K., Williams R.L., Katan M. Tyrosine residues in phospholipase Cgamma 2 essential for the enzyme function in B-cell signaling. J. Biol. Chem. 276:2001;47982-47992.
19. Watanabe D., Hashimoto S., Ishiai M., Matsushita M., Baba Y., Kishimoto T., Kurosaki T., Tsukada S. Four tyrosine residues in phospholipase C-gamma 2, identified as Btk-dependent phosphorylation sites, are required for B cell antigen receptor-coupled calcium signaling. J. Biol. Chem. 276:2001;38595-38601.
20. Takata M., Kurosaki T. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2. J. Exp. Med. 184:1996;31-40.
21. Takata M., Sabe H., Hata A., Inazu T., Homma Y., Nukada T., Yamamura H., Kurosaki T. Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways. EMBO J. 13:1994;1341-1349.
22. Takata M., Homma Y., Kurosaki T. Requirement of phospholipase C-gamma 2 activation in surface immunoglobulin M-induced B cell apoptosis [see comments]. J. Exp. Med. 182:1995;907-914.
23. Kurosaki T., Okada T. Regulation of phospholipase C-gamma2 and phosphoinositide 3-kinase pathways by adaptor proteins in B lymphocytes. Int. Rev. Immunol. 20:2001;697-711.
24. Lee S.B., Rhee S.G. Significance of PIP2 hydrolysis and regulation of phospholipase C isozymes. Curr. Opin. Cell Biol. 7:1995;183-189.
25. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature. 361:1993;315-325.
26. Berridge M.J., Bootman M.D., Lipp P. Calcium - a life and death signal. Nature. 395:1998;645-648.
27. Bootman M.D., Berridge M.J. The elemental principles of calcium signaling. Cell. 83:1995;675-678.
28. Imboden J.B., Stobo J.D. Transmembrane signalling by the T cell antigen receptor. Perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores. J. Exp. Med. 161:1985;446-456.
29. Scharenberg A.M., El-Hillal O., Fruman D.A., Beitz L.O., Li Z., Lin S., Gout I., Cantley L.C., Rawlings D.J., Kinet J.-P. Phosphatidylinositol-3,4,5- trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway a target for SHIP-mediated inhibitory signals . EMBO J. 17:1998;1961-1972.
30. Wakelam M.J. Diacylglycerol - when is it an intracellular messenger? Biochim. Biophys. Acta. 1436:1998;117-126.
31. Brose N., Rosenmund C. Move over protein kinase C, you've got company alternative cellular effectors of diacylglycerol and phorbol esters . J. Cell Sci. 115:2002;4399-4411.
32. 2+ entry evidence for a secretion-like coupling model . Cell. 98:1999;487-499.
33. Timmerman L.A., Clipstone N.A., Ho S.N., Northrop J.P., Crabtree G.R. Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression. Nature. 383:1996;837-840.
34. Rawlings D.J. Bruton's tyrosine kinase controls a sustained calcium signal essential for B lineage development and function [In Process Citation]. Clin. Immunol. 91:1999;243-253.
35. Petro J.B., Khan W.N. Phospholipase C-gamma 2 couples Bruton's tyrosine kinase to the NF-kappa B signaling pathway in B lymphocytes. J. Biol. Chem. 276:2001;1715-1719.
36. Petro J.B., Rahman S.M., Ballard D.W., Khan W.N. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement. J. Exp. Med. 191:2000;1745-1754.
37. Bajpai U.D., Zhang K., Teutsch M., Sen R., Wortis H.H. Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation. J. Exp. Med. 191:2000;1735-1744.
38. Emmel E.A., Verweij C.L., Durand D.B., Higgins K.M., Lacy E., Crabtree G. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science. 246:1989;1617-1620.
39. Boothby M., Liou H.-C., Glimcher L.H. Differences in DNA sequence specifically among MHC class II X box binding proteins. J. Immunol. 142:1989;1005-1014.
40. Lyakh L., Ghosh P., Rice N.R. Expression of NFAT-family proteins in normal human T cells. Mol. Cell Biol. 17:1997;2475-2484.
41. Petro J.B., Castro I., Lowe J., Khan W.N. Bruton's tyrosine kinase targets NF-kappaB to the bcl-x promoter via a mechanism involving phospholipase C-gamma2 following B cell antigen receptor engagement. FEBS Lett. 532:2002;57-60.
42. Antony P., Kanfer J.N., Freysz L. Phosphatidylcholine metabolism in nuclei of phorbol ester-activated LA-N-1 neuroblastoma cells. Neurochem. Res. 25:2000;1073-1082.
43. Folch-Pi J., Lees M., Sloan-Stanley G. A simple method for the isolation and purification of total lipids from the animal tissues. J. Biol. Chem. 226:1957;497-509.
44. Antony P., Farooqui A.A., Horrocks L.A., Freysz L. Effect of D609 on phosphatidylcholine metabolism in the nuclei of LA-N-1 neuroblastoma cells a key role for diacylglycerol . FEBS Lett. 509:2001;115-118.
45. Leray C., Pelletier X., Hemmendinger S., Cazenave J.P. Thin-layer chromatography of human platelet phospholipids with fatty acid analysis. J. Chromatogr. 420:1987;411-416.
46. Petro J.B., Gerstein R.M., Lowe J., Carter R.S., Shinners N., Khan W.N. Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen receptor signaling. J. Biol. Chem. 277:2002;48009-48019.
47. Fowell D.J., Shinkai K., Liao X.C., Beebe A.M., Coffman R.L., Littman D.R., Locksley R.M. Impaired NFATc translocation and failure of Th2 development in Itk-deficient CD4+ T cells. Immunity. 11:1999;399-409.
48. Yamamoto T., Matsuda T., Junicho A., Kishi H., Yoshimura A., Muraguchi A. Hematopoietic cell-specific adapter proteins, SLP-76 and BLNK, effectively activate NF-AT as well as NF-kappaB by Syk and Tec PTKs in non-lymphoid cell lines. FEBS Lett. 491:2001;272-278.
49. Macian F., Garcia-Cozar F., Im S.H., Horton H.F., Byrne M.C., Rao A. Transcriptional mechanisms underlying lymphocyte tolerance. Cell. 109:2002;719-731.
50. Rao A., Luo C., Hogan P.G. Transcription factors of the NFAT family regulation and function . Annu. Rev. Immunol. 15:1997;707-747.
51. Saijo K., Mecklenbrauker I., Santana A., Leitger M., Schmedt C., Tarakhovsky A. Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha. J. Exp. Med. 195:2002;1647-1652.
52. Su T.T., Guo B., Kawakami Y., Sommer K., Chae K., Humphries L.A., Kato R.M., Kang S., Patrone L., Wall R., Teitell M., Leitges M., Kawakami T., Rawlings D.J. PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 3:2002;780-786.
53. Choi M.S., Brines R.D., Holman M.J., Klaus G.G. Induction of NF-AT in normal B lymphocytes by anti-immunoglobulin or CD40 ligand in conjunction with IL-4. Immunity. 1:1994;179-187.
54. Venkataraman L., Francis D.A., Wang Z., Liu J., Rothstein T.L., Sen R. Cyclosporin-A sensitive induction of NF-AT in murine B cells. Immunity. 1:1994;189-196.
55. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:2000;95-105.
56. Uddin S., Sassano A., Deb D.K., Verma A., Majchrzak B., Rahman A., Malik A.B., Fish E.N., Platanias L.C. Protein kinase C-delta (PKC-delta) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J. Biol. Chem. 277:2002;14408-14416.
57. Coudronniere N., Villalba M., Englund N., Altman A. NF-kappa B activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta. Proc. Natl. Acad. Sci. USA. 97:2000;3394-3399.
58. Way K.J., Chou E., King G.L. Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol. Sci. 21:2000;181-187.
59. King L.B., Monroe J.G. Immunobiology of the immature B cell plasticity in the B-cell antigen receptor-induced response fine tunes negative selection . Immunol. Rev. 176:2000;86-104.
60. Berland R., Wortis H.H. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells. J. Immunol. 161:1998;277-285.
61. Berland R., Wortis H.H. Role of NFAT in the regulation of B-1 cells. Curr. Top Microbiol. Immunol. 252:2000;131-140.
62. Teutsch M., Higer M., Wang D., Wortis H.W. Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin. Int. Immunol. 7:1995;381-392.
63. Aifantis I., Gounari F., Scorrano L., Borowski C., von Boehmer H. Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobilization and activation of NF-kappaB and NFAT. Nat. Immunol. 2:2001;403-409.
64. Su T.T., Guo B., Kawakami Y., Sommer K., Chae K., Humphries L.A., Kato R.M., Kang S., Patrone L., Wall R., Teitell M., Leitges M., Kawakami T., Rawlings D.J. PKC-beta controls IkappaB kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 15:2002;15.
65. Peng S.L., Gerth A.J., Ranger A.M., Glimcher L.H. NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity. 14:2001;13-20.
66. Mond J.J., Scher I., Mosier D.E., Baese M., Paul W.E. T-independent responses in B cell-defective CBA/N mice to Brucella abortus and to trinitrophenyl (TNP) conjugates of Brucella abortus. Eur. J. Immunol. 8:1978;459-463.
67. Mosier D.E., Mond J.J., Goldings E.A. The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect. J. Immunol. 119:1977;1874-1878.
68. Yamada H., June C.H., Finkelman F., Brunswick M., Ring M.S., Lees A., Mond J.J. Persistent calcium elevation correlates with the induction of surface immunoglobulin-mediated B cell DNA synthesis. J. Exp. Med. 177:1993;1613-1621.
69. Finkelman F.D., Muul L.M., Yaffe L., Scher I., Mond J.J., Kessler S.W., Ryan J., Kung J.T., Metcalf E.S. Stimulation of the murine immune system by anti-IgD antibodies a polyclonal model of B-lymphocyte activation by a thymus dependent antigen . Ann. NY Acad. Sci. 399:1982;316-328.
70. Muul L.M., Scher I., Mond J.J., Finkelman F.D. Polyclonal activation of the murine immune system by an antibody to IgD. IV. In vivo activation of B lymphocytes from immune defective CBA/N mice. J. Immunol. 131:1983;2226-2231.
71. Khan W.N., Nilsson A., Mizoguchi E., Castigli E., Forsell J., Bhan A.K., Geha R., Sideras P., Alt F.W. Impaired B cell maturation in mice lacking Bruton's tyrosine kinase (Btk) and CD40. Int. Immunol. 9:1997;395-405.
72. Bendall H.H., Sikes M.L., Ballard D.W., Oltz E.M. An intact NF-kappa B signaling pathway is required for maintenance of mature B cell subsets. Mol. Immunol. 36:1999;187-195.
73. Ren H., Schmalstieg A., van Oers N.S., Gaynor R.B. I-kappa B kinases alpha and beta have distinct roles in regulating murine T cell function. J. Immunol. 168:2002;3721-3731.